Standardizing G8 evaluation

Durée : 15min. Anglais
Ce document est en accès libre.


Non-pharmaceutical innovations and public health

Management of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased risk of treatment-induced toxicity but also unexpected adverse events because of the underlying comorbidities and potential major consequences of these toxicities on the outcome because of frailty. In depth evaluation of the patient through geriatric assessment has been demonstrated as predictive of these adverse events but is time-consuming so that only a minority of cancer treatment hospitals will be able to propose it. Screening is part of the solution and G8 one of the best questionnaires currently available. Yet we have to go beyond this step and precisely define what to do for the unfit patients that we are now able to identify.

Cette présentation a été donnée dans le cadre du Scientific
BRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunir
tous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.


Cette fonction est inactive en démo.